Combination of Oridonin and Chlorin e6 with the metal–organic frameworks MIL‐101‐NH2‐AL for tumor chemo‐photodynamic therapy

Shilang Liao,Mengru Cai,Rongyue Zhu,Tingting Fu,Dongge Yin,Yuji Du,Yongqiang Zhang,Jiahui Kong,Jian Ni,Xingbin Yin
DOI: https://doi.org/10.1002/aoc.7335
IF: 3.9
2023-12-09
Applied Organometallic Chemistry
Abstract:It describes the loading of Oridonin and Chlorin e6 into MIL‐101‐NH2‐AL and exerts chemotherapy combined with photodynamic therapy on hepatocellular carcinoma cells. In this paper, a metal–organic skeleton material MIL‐101‐NH2‐AL was prepared for loading the chemotherapeutic drug Oridonin (Ori) and photosensitizer Chlorin e6 (Ce6). A drug delivery system for synergistic chemotherapy and photodynamic therapy was constructed. At the same time, we evaluated MIL‐101‐NH2‐AL as a drug therapy carrier, including drug loading, cytotoxicity, and safety, verified the photodynamic efficiency of MIL‐101‐NH2‐AL@Ori@Ce6 in vitro, and studied the ability of MIL‐101‐NH2‐AL@Ori@Ce6 cancer cells to produce reactive oxygen species, cell uptake, cytotoxicity, and so on. Experiments have confirmed that MIL‐101‐NH2‐AL, as a nano‐carrier, encapsulated Oridonin and Ce6, the combination of PDT and chemotherapy showed enhanced tumor inhibition and high biosafety. The killing effect on cells was caused by reactive oxygen species produced by photosensitizers and apoptosis of tumor cells induced by Oridonin. The drug delivery system demonstrates enormous potential for synergistic anti‐tumor effects of photodynamic and chemotherapy.
chemistry, inorganic & nuclear, applied
What problem does this paper attempt to address?